Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

Summary

The primary purpose of this study is to determine the efficacy and safety of three dose levels of cobiprostone as compared to placebo in OA/RA patients treated with an NSAID for 20 months.

Timeline

Start

2007-08

Primary completion

2009-04

Completion

2009-05

Drugs

Indications